{"id":382585,"date":"2020-11-17T06:03:16","date_gmt":"2020-11-17T11:03:16","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=382585"},"modified":"2020-11-17T06:03:16","modified_gmt":"2020-11-17T11:03:16","slug":"nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\/","title":{"rendered":"NanoString and Oregon Health &amp; Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>NanoString and Oregon Health &amp; Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer<\/b><\/p>\n<p class=\"bwalignc\">\nSpatial Analysis of up to 30 Proteins on FFPE Tumor Biopsies May Inform Patient Treatment Decisions\n<\/p>\n<p>SEATTLE&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nNanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced a collaboration with Oregon Health &amp; Science University (OHSU) for their development of novel GeoMx\u00ae Digital Spatial Profiler (DSP) protein assays to spatially profile breast cancer. These assays will be designed to enhance breast cancer tumor analysis and may inform clinical decision-making of patient treatment options. The work will be performed under the GeoMx Translational Leadership Network (GTLN), and the newly formed GeoMx Clinical Consortium, with the goal of developing clinical applications on the GeoMx DSP platform.\n<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20201117005550\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20201117005550\/en\/<\/a><\/p>\n<div id=\"bwbodyimg\" style=\"width: 480px;float:left;padding-left:0px;padding-right:20px;padding-top:0px;padding-bottom:0px\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20201117005550\/en\/839366\/4\/DSP_nanoString-9642.jpg\" alt=\"GeoMx Digital Spatial Profiler. (Photo: Business Wire)\" \/><\/p>\n<p style=\"font-size:85%\">GeoMx Digital Spatial Profiler. (Photo: Business Wire)<\/p>\n<\/div>\n<p>\nUnder the collaboration, pathologists at OHSU intend to design a new GeoMx protein assay with up to 30 targets, including existing breast cancer diagnostic markers and novel biomarker candidates. The GeoMx protein assays will be analytically and clinically validated by OHSU for potential use as laboratory developed tests. The development of a high-content spatial protein test using GeoMx may present new opportunities to enhance pathology insights for improved patient outcomes.\n<\/p>\n<p>\n\u201cWe believe that the GeoMx DSP is the only spatial platform with the potential to serve the needs of discovery research, translational research, and clinical diagnostics,\u201d said Brad Gray, president &amp; CEO of NanoString. \u201cOHSU is a great partner to advance the platform towards the clinical environment and we look forward to collaborating with these thought leaders.\u201d\n<\/p>\n<p>\n\u201cThe development of novel GeoMx DSP protein assays expands the potential applications of spatial biology with the goal of providing better patient care through advanced molecular testing,\u201d said Christopher Corless, MD, PhD, Executive Director, Knight Diagnostic Laboratories at the OHSU Knight Cancer Institute. \u201cThe GeoMx DSP platform is uniquely suited for this work based on the high-plex and automated capabilities of the system for use with formalin-fixed paraffin-embedded samples.\u201d\n<\/p>\n<p>\nDr. Corless of OHSU will present his GeoMx DSP research at the Association for Molecular Pathology (AMP) 2020 Annual Meeting &amp; Expo, which will be held virtually November 16-20.\n<\/p>\n<p>\nTo learn more about NanoString\u2019s GeoMx Digital Spatial Profiler, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.nanostring.com%2Fproducts%2Fgeomx-digital-spatial-profiler%2Fgeomx-dsp&amp;esheet=52329427&amp;newsitemid=20201117005550&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.nanostring.com%2Fproducts%2Fgeomx-digital-spatial-profiler%2Fgeomx-dsp&amp;index=1&amp;md5=2bf8cf18d0c335068c1dd50744cbd007\">https:\/\/www.nanostring.com\/products\/geomx-digital-spatial-profiler\/geomx-dsp<\/a>.\n<\/p>\n<p><b>About NanoString Technologies, Inc. <\/b><\/p>\n<p>\nNanoString Technologies is a leading provider of life science tools for discovery and translational research. The company\u2019s nCounter\u00ae Analysis System is used in life sciences research and has been cited in more than 3,800 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company\u2019s GeoMx\u00ae Digital Spatial Profiler enables highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections.\n<\/p>\n<p>\nFor more information, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.nanostring.com&amp;esheet=52329427&amp;newsitemid=20201117005550&amp;lan=en-US&amp;anchor=www.nanostring.com&amp;index=2&amp;md5=6145ae21c3e213730498483d0ddd920c\">www.nanostring.com<\/a>.\n<\/p>\n<p><i>NanoString, NanoString Technologies, the NanoString logo, GeoMx, and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions. <\/i><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201117005550r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20201117005550\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20201117005550\/en\/<\/a><\/span><\/p>\n<p><b>Doug Farrell, NanoString<br \/>\n<\/b><br \/>Vice President, Investor Relations &amp; Corporate Communications<br \/>\n<br \/><b><a rel=\"nofollow\" href=\"mailto:dfarrell@nanostring.com\">dfarrell@nanostring.com<br \/>\n<\/a><\/b><br \/><b>Phone: 206-602-1768<\/b><\/p>\n<p><b>KEYWORDS:<\/b> Oregon Washington United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Research Medical Devices Genetics Biotechnology Health University Science Education Oncology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20201117005550\/en\/756482\/3\/NSTG_Logo_2020.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20201117005550\/en\/839366\/3\/DSP_nanoString-9642.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">GeoMx Digital Spatial Profiler. (Photo: Business Wire)<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>NanoString and Oregon Health &amp; Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer Spatial Analysis of up to 30 Proteins on FFPE Tumor Biopsies May Inform Patient Treatment Decisions SEATTLE&#8211;(BUSINESS WIRE)&#8211; NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced a collaboration with Oregon Health &amp; Science University (OHSU) for their development of novel GeoMx\u00ae Digital Spatial Profiler (DSP) protein assays to spatially profile breast cancer. These assays will be designed to enhance breast cancer tumor analysis and may inform clinical decision-making of patient treatment options. The work will be performed under the GeoMx Translational Leadership Network (GTLN), and the newly formed GeoMx Clinical Consortium, with &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NanoString and Oregon Health &amp; Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-382585","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NanoString and Oregon Health &amp; Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NanoString and Oregon Health &amp; Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NanoString and Oregon Health &amp; Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer Spatial Analysis of up to 30 Proteins on FFPE Tumor Biopsies May Inform Patient Treatment Decisions SEATTLE&#8211;(BUSINESS WIRE)&#8211; NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced a collaboration with Oregon Health &amp; Science University (OHSU) for their development of novel GeoMx\u00ae Digital Spatial Profiler (DSP) protein assays to spatially profile breast cancer. These assays will be designed to enhance breast cancer tumor analysis and may inform clinical decision-making of patient treatment options. The work will be performed under the GeoMx Translational Leadership Network (GTLN), and the newly formed GeoMx Clinical Consortium, with &hellip; Continue reading &quot;NanoString and Oregon Health &amp; Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-17T11:03:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20201117005550\/en\/839366\/4\/DSP_nanoString-9642.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NanoString and Oregon Health &amp; Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer\",\"datePublished\":\"2020-11-17T11:03:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\\\/\"},\"wordCount\":615,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20201117005550\\\/en\\\/839366\\\/4\\\/DSP_nanoString-9642.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\\\/\",\"name\":\"NanoString and Oregon Health &amp; Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20201117005550\\\/en\\\/839366\\\/4\\\/DSP_nanoString-9642.jpg\",\"datePublished\":\"2020-11-17T11:03:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20201117005550\\\/en\\\/839366\\\/4\\\/DSP_nanoString-9642.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20201117005550\\\/en\\\/839366\\\/4\\\/DSP_nanoString-9642.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NanoString and Oregon Health &amp; Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NanoString and Oregon Health &amp; Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\/","og_locale":"en_US","og_type":"article","og_title":"NanoString and Oregon Health &amp; Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer - Market Newsdesk","og_description":"NanoString and Oregon Health &amp; Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer Spatial Analysis of up to 30 Proteins on FFPE Tumor Biopsies May Inform Patient Treatment Decisions SEATTLE&#8211;(BUSINESS WIRE)&#8211; NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced a collaboration with Oregon Health &amp; Science University (OHSU) for their development of novel GeoMx\u00ae Digital Spatial Profiler (DSP) protein assays to spatially profile breast cancer. These assays will be designed to enhance breast cancer tumor analysis and may inform clinical decision-making of patient treatment options. The work will be performed under the GeoMx Translational Leadership Network (GTLN), and the newly formed GeoMx Clinical Consortium, with &hellip; Continue reading \"NanoString and Oregon Health &amp; Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-17T11:03:16+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20201117005550\/en\/839366\/4\/DSP_nanoString-9642.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NanoString and Oregon Health &amp; Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer","datePublished":"2020-11-17T11:03:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\/"},"wordCount":615,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20201117005550\/en\/839366\/4\/DSP_nanoString-9642.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\/","name":"NanoString and Oregon Health &amp; Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20201117005550\/en\/839366\/4\/DSP_nanoString-9642.jpg","datePublished":"2020-11-17T11:03:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20201117005550\/en\/839366\/4\/DSP_nanoString-9642.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20201117005550\/en\/839366\/4\/DSP_nanoString-9642.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanostring-and-oregon-health-science-university-announce-collaboration-to-develop-geomx-based-spatial-profiling-assays-for-breast-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NanoString and Oregon Health &amp; Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/382585","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=382585"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/382585\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=382585"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=382585"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=382585"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}